Prils Market Size

  • Report ID: 4109
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Prils Market Size

Prils Market size was valued at USD 2.27 billion in 2024 and is expected to reach USD 5.08 billion by 2037, expanding at around 6.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of prils is evaluated at USD 2.51 billion.

The growth of the market can be attributed to the increasing prevalence of high blood pressure. Lifestyle modifications and appropriate medication, such as prils, are frequently used to treat the disease.

When more people are diagnosed with hypertension and given prescriptions for blood pressure management, in turn, could increase the demand for market. According to estimates over 69 million senior adults in India are expected to have hypertension by the year 2050.

Factors that are believed to fuel the prils market growth include the rise in the pharmaceutical industry across the globe. As more people gain access to the medication, there may be an increase in demand as a result of greater accessibility and availability of prils in hospitals, pharmacies, and other locations.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4109
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of prils is evaluated at USD 2.51 billion.

The prils market size was valued at USD 2.27 billion in 2024 and is expected to reach USD 5.08 billion by 2037, expanding at around 6.4% CAGR during the forecast period i.e., between 2025-2037. Rising geriatric population and the growing incidences of cardiovascular diseases will boost the market growth.

Europe industry is predicted to account for largest revenue share of 31% by 2037, driven by increasing initiatives to assist the expansion of generic medications through pricing and reimbursement in the region.

The major players in the market are Teva Pharmaceuticals Industries Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Mylan N.V, F. Hoffmann-La Roche Ltd., Novartis AG, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Lupin Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample